In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 490 for your search:
Drug:  rituximab
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: 40 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 102-12, NCT00090038

2.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: 15 to 65
Sponsor: Other
Protocol IDs: GMALL03, NCT00199004

3.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: 18 to 120
Sponsor: Pharmaceutical / Industry
Protocol IDs: MO19872, NCT00430352

4.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: 18 to 70
Sponsor: Other
Protocol IDs: 2006-003750-23, LINFOTARGAM, NCT00466258

5.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: MO22468, 2009-012072-28, NCT01056510

6.

Phase: Phase IV
Type: Treatment
Status: Closed
Age: 60 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: ML25137, NCT01283386

7.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: 18 to 60
Sponsor: Other
Protocol IDs: RJ-2010-56, NCT01358253

8.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 20 to 69
Sponsor: Other
Protocol IDs: JCOG0203, C000000033, NCT00147121

9.

Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: IL2NHL03, UCLA-0302013, CHIR-IL2NHL03-A01, NCT00045877

10.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CC-5013-DLC-001, NCT01197560

11.

Phase: Phase III, Phase II
Type: Natural history/Epidemiology, Supportive care
Status: Closed
Age: 18 to 75
Sponsor: Other
Protocol IDs: 201010HBV, NCT01210287

12.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 15 to 65
Sponsor: NCI, Other
Protocol IDs: CDR0000065658, S9704, U10CA032102, SWOG-S9704, CAN-NCIC-LY11, CALGB-59903, ECOG-S9704, LY11, NCT00004031

13.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 60 and over
Sponsor: NCI
Protocol IDs: ECOG-E4494, E4494, CLB-9793, SWOG-E4494, NCT00003150

14.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: SAKK 35/98, SWS-SAKK-35/98, ICR-35/98, EU-98009, NCT00003280

15.

Phase: Phase III
Type: Treatment
Status: Closed
Age: Not specified
Sponsor: Pharmaceutical / Industry
Protocol IDs: IDEC-106-04, MAYO-977802

16.

Phase: Phase III
Type: Treatment
Status: Completed
Age: Over 18
Sponsor: NCI
Protocol IDs: NCI-2012-02279, AMC-010, CPMC-IRB-9691, CWRU-AMC-1400, UCLA-9810029, CDR0000066666, NCT00003595

17.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: IDEC-106-06, MAYO-987804, UCLA-9808026

18.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 19 and over
Sponsor: NCI, Other
Protocol IDs: 447-97, P30CA036727, UNMC-447-97, UCLA-HSPC-9812071, NCI-G99-1601, NCT00004112

19.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000067393, EORTC-20981, ALLG-NHLLOW4, BNLI-EORTC-20981, HOVON-H039, CAN-NCIC-LY7, NORDIC-EORTC-20981, LY7, NCT00004179

20.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: EBMT-EBMTLYM1, BNLI-EBMT-EBMTLYM1, EU-99050, NCT00005589

21.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000068321, U10CA032102, S0016, CALGB-50102, SWOG-S0016, ECOG-SWOG-S0016, NCT00006721

22.

Phase: Phase III
Type: Treatment
Status: Unknown
Age: 18 to 65
Sponsor: Other
Protocol IDs: CKTO-2000-06, HOVON-44, HOVON-44/CKVO-2000-06, EU-20042, ISRCTN95614846, NCT00012051

23.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 65 and over
Sponsor: Other
Protocol IDs: CKTO-2000-10, HOVON-46NHL, EU-20130, HOVON-CKVO-2000-10, NCT00028717

24.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 to 70
Sponsor: NCI
Protocol IDs: ECOG-E2499, CALGB-50205, CALGB-E2499, NCT00052923, E2499

25.

Phase: Phase III
Type: Health services research, Treatment
Status: Closed
Age: 61 to 80
Sponsor: Other
Protocol IDs: CDR0000269015, DSHNHL-1999-1A, EU-20243, NCT00052936
1     
New Search